You just read:

Chiesi Farmaceutici and Cornerstone Therapeutics Announce Agreement for a Merger Transaction in Which Chiesi Will Acquire 100 Percent Ownership of Cornerstone for $9.50 Per Share in Cash

News provided by

Chiesi Farmaceutici S.p.A & Cornerstone Therapeutics Inc.

16 Sep, 2013, 14:14 BST